RACA · Categories · Form 3

RACA - SEC Form 3 initial insider statements

Therapeutics Acquisition Corp. (RACA) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for RACA

• 1760d
  SEC Form 3 filed by JENSEN JESSICA D.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by Malik Rajesh

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by MARGOLIN YAEL

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by MCCANN JOE A.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by SILBER ALLAN C

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by GOTTLIEB MICHAEL M.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by HOGUE GERALD L.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by Therapeutics Acquisition Corp.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by GILMOUR MARGARET E.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by FLESHNER NEIL E.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by DEMERS WILLIAM L.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1766d
  SEC Form 3: RA CAPITAL MANAGEMENT, L.P. claimed ownership of 889,218 units of Common Stock

  3 - Therapeutics Acquisition Corp. (0001811764) (Issuer)

Other RACA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends